Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-30

FDA Approved: ATOMOXETINE HYDROCHLORIDE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s generic atomoxetine hydrochloride as an original ANDA for the treatment of attention-deficit/hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atomoxetine hydrochloride (Atomoxetine hydrochloride)

Snippet

ORIG AP for ATOMOXETINE HYDROCHLORIDE (ATOMOXETINE HYDROCHLORIDE)